Is Astrazeneca Pharma India a good stock to invest in?

Astrazeneca Pharma India can be analyzed on the following key metrics - TTM P/E: 81.89 Sector P/E: 26.61 Dividend Yield: 0.46 D/E ratio: 0.01

Astrazeneca Pharma India

Sector: Major Drugs

Powered by

3502.0 +2.45 (0.07%)Updated : Fri Jun 02 2023 09:59:23

Price Range

Today’s Low3478.05

Today’s High3614.8

52 Week Low2650.0

52 Week High3619.7

Key Metrics

Market Cap (In Cr) 8756.25
Beta 0.46
Div. Yield (%) 0.46
P/B 14.87
TTM P/E 81.89
Peg Ratio 1.43
Sector P/E 26.61
D/E 0.01
Open Price 3577.40
Prev Close 3499.55

View All Metrics

Astrazeneca Pharma India Analysis

Price Analysis

1 Week
8.81%
3 Month
2.75%
6 Month
5.19%
YTD
6.23%
1 Year
18.95%

Risk Meter

21%Moderate risk
21%Moderate risk
21%Moderate risk
21%Moderate risk
21%Moderate risk

Astrazeneca Pharma India Financials

INCOME
BALANCE SHEET
Cashflow

Annual

Quarterly

Period	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Total Revenue	1002.97	805.60	813.56	831.81
Selling/ General/ Admin Expenses Total	320.51	343.64	326.58	356.29
Depreciation/ Amortization	16.26	16.95	20.13	18.58
Other Operating Expenses Total	157.35	10.09	13.06	12.29
Total Operating Expense	894.33	736.24	697.68	729.25
Operating Income	108.64	69.36	115.88	102.56
Net Income Before Taxes	134.10	83.04	127.09	113.97
Net Income	99.29	61.60	93.30	72.21
Diluted Normalized EPS	51.64	23.80	36.68	28.81

View detailed financials

Forecast

Income Sheet (In Cr)Net Income Vs Revenue

Returns Metrics (In Cr)ROA Vs ROE

Astrazeneca Pharma India Technical

Simple Moving Average

5 Day 3313.63
10 Day 3255.86
20 Day 3256.16

50 Day 3247.65
100 Day 3303.92
300 Day 3263.58

Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Aurobindo Pharma
661.1
-1.5
-0.23
667.35
397.3
38736.4

Pfizer
3845.75
34.15
0.9
4662.35
3406.95
17593.43

Astrazeneca Pharma India
3502
2.45
0.07
3619.7
2650
8755

Neuland Laboratories
2796.6
60.25
2.2
3040.35
1007.7
3607.75

Unichem Laboratories
371.25
-0.6
-0.16
467
229.7
2613.81

Astrazeneca Pharma India Shareholding

Shareholding Pattern

Shareholding Trend

0

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meetings
AGM
Dividends
Bonus
Split
Rights

Meeting Date	Purpose
30-May-23	Audited Results & Dividend
10-Feb-23	Quarterly Results
11-Nov-22	Quarterly Results
08-Aug-22	Quarterly Results
26-May-22	Audited Results & Final Dividend
08-Feb-22	Quarterly Results
09-Nov-21	Quarterly Results
09-Aug-21	Quarterly Results & Interim Dividend
25-May-21	Audited Results
08-Feb-21	Quarterly Results

View All

Company Profile

ABOUT Astrazeneca Pharma India

Industry Major Drugs
ISIN INE203A01020
BSE Code 506820
NSE Code ASTRAZEN

AstraZeneca Pharma India Limited is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas, such as oncology, cardiovascular, renal and metabolism, and respiratory. It also provides clinical trial services. Its cardiovascular disease and diabetic medicine brands include Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL and Xigduo XR. Its respiratory medicine brands include Symbicort and FASENRA. Its oncology medicine brands include LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex and Arimidex. It provides services, such as self-management, diabetes diet and nutrition plans, and free telephonic counseling to patients. It operates in over 100 countries.

MANAGEMENT

Rajesh Marwaha Chief Financial Officer, Whole-Time Director
Bhavana Agrawal Chief Financial Officer
Manasa. R Compliance Officer, Company Secretary
Sanjeev Panchal Managing Director, Additional Director

Astrazeneca Pharma India SUMMARY

Astrazeneca Pharma India is trading 0.07% upper at Rs 3502.00 as compared to its last closing price. Astrazeneca Pharma India has been trading in the price range of 3614.80 & 3478.05. Astrazeneca Pharma India has given 6.23% in this year & 8.81% in the last 5 days.

Astrazeneca Pharma India has TTM P/E ratio 81.89 as compared to the sector P/E of 26.61.

The company posted a net profit of 17.27 Crores in its last quarter.

Listed peers of Astrazeneca Pharma India include Aurobindo Pharma (-0.23%), Pfizer (0.90%), Astrazeneca Pharma India (0.07%) etc.

FAQs about Astrazeneca Pharma India

Astrazeneca Pharma India is trading at 3502.00 as on Fri Jun 02 2023 09:59:23. This is 0.07% upper as compared to its previous closing price of 3499.55.

The market capitalization of Astrazeneca Pharma India is 8755.00 Cr as on Fri Jun 02 2023 09:59:23.

The 52 wk high for Astrazeneca Pharma India is 3619.70 whereas the 52 wk low is 2650.00

Astrazeneca Pharma India can be analyzed on the following key metrics -

TTM P/E: 81.89
Sector P/E: 26.61
Dividend Yield: 0.46%
D/E ratio: 0.01

Astrazeneca Pharma India reported a net profit of 99.29 Cr in 2023.

Astrazeneca Pharma India Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Trending Stocks

Trending Mutual Funds

Astrazeneca Pharma India